1 completed, 1 not yet recruiting, 1 unknown. 3 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 3 | Completed 1, Not yet recruiting 1, Unknown 1 |
Follow Keratoconus: new trials by email Literature Review of Keratoconus trials Research Report on Keratoconus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treating Corneal Thinning Conditions With CCL Vario Riboflavin (CXL) Riboflavin - Keratoconus, Unstable | Early Phase 1 | Not yet recruiting | Kent Wellish MD | 600 | 2021-06-30 | 2021-05-25 |
| Safety and Efficacy of Intracanalicular Dexamethasone Compared to Loteprednol Etabonate in Patients With Keratoconus dexamethasone ophthalmic insert 0.4 mg, for intracanalicular use, Loteprednol Etabonate 0.38% Ophthalmic Gel/Jelly - Keratoconus, Dry Eye | Early Phase 1 | Completed | Illinois College of Optometry | 36 | 2020-09-01 | 2026-06-24 |
| Autologous Adipose-Derived Adult Stem Cell Transplantation for Corneal Diseases Lipoaspiration, Transplantation - Hereditary Corneal Dystrophy, Keratoconus | Early Phase 1 | Unknown | Vissum, Instituto Oftalmológico de Alicante | 12 | 2015-11-01 | 2016-10-13 |
Corneal Diseases (1) · Corneal Dystrophies, Hereditary (1) · Dry Eye Syndromes (1) · Hypersensitivity (1)
Eye Diseases (3) · Corneal Diseases (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Eye Diseases, Hereditary (1) · Genetic Diseases, Inborn (1) · Immune System Diseases (1) · Lacrimal Apparatus Diseases (1)
Calcium Dobesilate (1) · Loteprednol Etabonate (1) · Riboflavin (1) · Transplantation (1) · Ultraviolet Rays (1)
Illinois College of Optometry (1) · Kent Wellish MD (1) · Vissum, Instituto Oftalmológico de Alicante (1)
Lebanon (1) · United States (1)
Jennifer Harthan (1) · Kent L Wellish, MD (1) · Mona El Zarif, OD (1)